• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    KaloBios Pharmaceuticals, Inc. (KBIO)

    -NasdaqGM
    0.49 Down 0.01(1.80%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.50
    Open:0.49
    Bid:N/A
    Ask:0.56 x 1000
    1y Target Est:5.00
    Beta:4.24
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:0.46 - 0.51
    52wk Range:0.36 - 2.34
    Volume:177,682
    Avg Vol (3m):658,743
    Market Cap:16.17M
    P/E (ttm):N/A
    EPS (ttm):-1.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    KBIODown 1.80%16.17M
    VRTXUp 4.02%31.99B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.17
    Quarterly EPS Est (Jun-15) :-0.21
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, develops monoclonal antibody therapeutics for the treatment of cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback